争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 1 条
2022
勃林格殷格翰就 Jardiance 专利起诉 Laurus
提起诉讼
勃林格殷格翰制药及相关实体在特拉华州起诉 Laurus Labs 和 Laurus Generics，指控其涉及 Jardiance 仿制药的专利侵权，并寻求禁令救济和金钱赔偿。
来源摘录
The plaintiff is suing for patent infringement and seeks declaratory judgment of infringement as well as injunctive relief preventing further infringement and monetary damages.
On Friday a case was filed in the District of Delaware by Boehringer Ingelheim Pharmaceuticals Inc., and related entities against Laurus Labs LTD and Laurus Generics Inc. The case is regarding patent infringement for the drug Jardiance.
Merck is seeking declaratory judgement of patent infringement after the defendants submitted an Abbreviated New Drug Application (ANDA) to the Food and Drug Administration (FDA) to produce a generic version of the plaintiff’s diabetes treatment.